Phosphofructokinase Muscle-Specific Isoform Requires Caveolin-3 Expression for Plasma Membrane Recruitment and Caveolar Targeting: Implications for the Pathogenesis of Caveolin-Related Muscle Diseases

American Journal of Pathology

Volumn 163, Issue 6, 2003, Pages 2619-2634

  Sotgia, Federica ^a,c   Bonuccelli, Gloria ^a,c   Minetti, Carlo ^c   Woodman, Scott E ^a   Capozza, Franco ^a   Kemp, Robert G ^b   Scherer, Philipp E ^a   Lisanti, Michael P ^a,d  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b The Chicago Medical College   (United States)

^c UNIVERSITY OF GENOA   (Italy)

^d Golding Bldg ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTOKINASE ISOENZYME M; CAVEOLIN 3; MUTANT PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CAVEOLA; CELL MEMBRANE; CONTROLLED STUDY; DISTAL MYOPATHY; ENZYME LOCALIZATION; ENZYME SPECIFICITY; GENE MUTATION; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; LIMB GIRDLE MUSCULAR DYSTROPHY; MOUSE; MUSCLE DISEASE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; PROTEIN TRANSPORT; REDUCTION; REGULATORY MECHANISM; RIPPLING MUSCLE DISEASE; SKELETAL MUSCLE;

EID: 0344412990     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63616-4     Document Type: Article

References (55)

1. Kemp RG, Foe LG: Allosteric regulatory properties of muscle phosphofructokinase. Mol Cell Biochem 1983, 57:147-154
2. Tsai MY, Kemp RG: Hybridization of rabbit muscle and liver phosphofructokinases. Arch Biochem Biophys 1972, 150:407-411
3. Dunaway GA, Kasten TP, Sebo T, Trapp R: Analysis of the phosphofructokinase subunits and isoenzymes in human tissues. Biochem J 1988, 251:677-683
4. Vora S, Seaman C, Durham S, Piomelii S: Isozymes of human phosphofructokinase: identification and subunit structural characterization of a new system Proc Natl Acad Sci USA 1980, 77:62-66
5. Vora S: Isozymes of human phosphofructokinase in blood cells and cultured cell lines: molecular and genetic evidence for a trigenic system. Blood 1981, 57:724-732
6. Vora S, Wims LA, Durham S, Morrison SL: Production and characterization of monoclonal antibodies to the subunits of human phosphofructokinase: new tools for the immunochemical and genetic analyses of isozymes. Blood 1981, 58:823-829
7. Tarui S, Okuno G, Ikura Y, Tanaka T, Suda M: Phosphofructokinase deficiency in skeletal muscle, a new type of glycogenosis Biochem Biophys Res Commun 1965, 19:517-523
8. Vora S, Davidson M, Seaman C, Miranda AF, Noble NA, Tanaka KR, Frenkel EP, DiMauro S: Heterogeneity of the molecular lesions in inherited phosphofructokinase deficiency. J Clin Invest 1983, 72: 1995-2006
9. Lehotzky A, Telegdi M, Liliom K, Ovadi J: Interaction of phosphofructokinase with tubulin and microtubules. Quantitative evaluation of the mutual effects. J Biol Chem 1993, 268:10888-10894
10. Kraft T, Hornemann T, Stolz M, Nier V, Wallimann T: Coupling of creatine kinase to glycolytic enzymes at the sarcomeric I-band of skeletal muscle: a biochemical study in situ J Muscle Res Cell Motil 2000, 21:691-703
11. Hazen SL, Gross RW: The specific association of a phosphofructokinase isoform with myocardial calcium-independent phospholipase A2 Implications for the coordinated regulation of phospholipolysis and glycolysis. J Biol Chem 1993, 268:9892-9900
12. Reiss N, Kanety H, Schlessinger J: Five enzymes of the glycolytic pathway serve as substrates for purified epidermal-growth-factor-receptor kinase. Biochem J 1986, 239:691-697
13. Sale EM, White MF, Kahn CR: Phosphorylation of glycolytic and gluconeogenic enzymes by the insulin receptor kinase. J Cell Biochem 1987, 33:15-26
14. Firestein BL, Bredt DS: Interaction of neuronal nitric-oxide synthase and phosphofructokinase-M. J Biol Chem 1999, 274:10545-10550
15. Roberts CK, Barnard RJ, Jasman A, Balon TW: Acute exercise increases nitric oxide synthase activity in skeletal muscle. Am J Physiol 1999, 277:E390-E394
16. Lisanti MP, Scherer P, Tang, ZL, Sargiacomo M: Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis. Trends Cell Biol 1994, 4:231-235
17. Smart EJ, Graf GA, McNiven MA, Sessa WC, Engelman JA, Scherer PE, Okamoto T, Lisanti MP: Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol 1999, 19:7289-7304
18. Galbiati F, Razani B, Lisanti MP: Emerging themes in lipid rafts and caveolae Cell 2001, 106:403-411
19. Glenney JR, Soppet D: Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in RSV-transformed fibroblasts. Proc Natl Acad Sci USA 1992, 89:10517-10521
20. Scherer PE, Okamoto T, Chun M, Nishimoto I, Lodish HF, Lisanti MP: Identification, sequence and expression of caveolin-2 defines a caveolin gene family. Proc Nati Acad Sci USA 1996, 93:131-135
21. Tang ZL, Scherer PE, Okamoto T, Song K, Chu C, Kohtz DS, Nishimoto I, Lodish HF, Lisanti MP: Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 1996, 271:2255-2261
22. Way M, Parton R: M-caveolin, a muscle-specific caveolin-related protein. FEBS Lett 1995, 376:108-112
23. Scherer PE, Lewis RY, Volonte D, Engelman JA, Galbiati F, Couet J, Kohtz DS, van Donselaar E, Peters P, Lisanti MP: Cell-type and tissue-specific expression of caveolin-2 Caveolins 1 and 2 colocalize and form a stable hetero-oligomeric complex in vivo. J Biol Chem 1997, 272:29337-29346
24. Song KS, Scherer PE, Tang Z-L, Okamoto T, Li S, Chafel M, Chu C, Kohtz DS, Lisanti MP: Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem 1996, 271:15160-15165
25. Sargiacomo M, Scherer PE, Tang Z-L, Kubler E, Song KS, Sanders MC, Lisanti MP: Oligomeric structure of caveolin: implications for caveolae membrane organization. Proc Natl Acad Sci USA 1995, 92:9407-9411
26. Monier S, Parton RG, Vogel F, Behlke J, Henske A, Kurzchalia T: VLP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro. Mol Biol Cell 1995, 6:911-927
27. Galbiati F, Engelman JA, Volonte D, Zhang XL, Minetti C, Li M, Hou HJ, Kneitz B, Edelmann W, Lisanti MP: Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and T-tubule abnormalities J Biol Chem 2001, 276:21425-21433
28. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, Di Vizio D, Hou HJ, Kneitz B, Lagaud G, Christ GJ, Edelmann W, Lisanti, MP: Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities J Biol Chem 2001, 276:38121-38138
29. Razani B, Wang XB, Engelman JA, Battista M, Lagaud G, Zhang XL, Kneitz B, Hou Jr H, Christ GJ, Edelmann W, Lisanti MP: Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae. Mol Cell Biol 2002, 22:2329-2344
30. Sotgia F, Lee JK, Das K, Bedford M, Petrucci TC, Macioce P, Sargiacomo M, Bricarelli FD, Minetti C, Sudol M, Lisanti MP: Caveolin-3 directly interacts with the C-terminal tail of beta-dystroglycan. Identification of a central WW-like domain within caveolin family members. J Biol Chem 2000, 275:38048-38058
31. Garcia-Cardena G, Martasek P, Siler-Masters BS, Skidd PM, Couet JC, Li S, Lisanti MP, Sessa WC: Dissecting the interaction between nitric oxide synthase (NOS) and caveolin: functional significance of the NOS caveolin binding domain in vivo. J Biol Chem 1997, 272: 25437-25440
32. Venema VJ, Ju H, Zou R, Venema RC: Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain. J Biol Chem 1997, 272: 28187-28190
33. Minetti C, Sotgia F, Bruno C, Seartezzini P, Broda P, Bado M, Masetti E, Mazzocco M, Egeo A, Donati MA, Volonte D, Galbiati F, Cordone G, Bricarelli FD, Lisanti MP, Zara F: Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet 1998, 18:365-368
34. Carbone I, Bruno C, Sotgia F, Bado M, Broda P, Masetti E, Panella A, Zara F, Bricarelli FD, Cordone G, Lisanti MP, Minetti C: Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Neurology 2000, 54:1373-1376
35. Betz RC, Schoser BG, Kasper D, Ricker K, Ramirez A, Stein V, Torbergsen T, Lee YA, Nothen MM, Wienker TF, Malin JP, Propping P, Reis A, Mortier W, Jentsch TJ, Vorgerd M, Kubisch C: Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Nat Genet 2001, 28:218-219
36. Tateyama M, Aoki M, Nishino I, Hayashi YK, Sekiguchi S, Shiga Y, Takahashi T, Onodera Y, Haginoya K, Kobayashi K, Iinuma K, Nonaka I, Arahata K, Itoyama Y, Itoyoma Y: Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy. Neurology 2002, 58:323-325
37. Scherer PE, Lisanti MP: Association of phosphofructokinase-M with caveolin-3 in differentiated skeletal myotubes: dynamic regulation by extracellular glucose and intracellular metabolites. J Biol Chem 1997, 272:20698-20705
38. Galbiati F, Volonte D, Minetti C, Chu JB, Lisanti MP: Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C) J Biol Chem 1999, 274: 25632-25641
39. Sotgia F, Woodman SE, Bonuccelli G, Capozza F, Minetti C, Scherer PE, Lisanti MP: Phenotypic behavior of caveolin-3 R26Q, a mutant associated with hyperCKemia, distal myopathy, and rippling muscle disease. Am J Physiol Cell Physiol 2003, 285: C1150-C1160
40. Song KS, Tang ZL, Li S, Lisanti MP: Mutational analysis of the properties of caveolin-1. A novel role for the C-terminal domain in mediating homotypic caveolin-caveolin interactions. J Biol Chem 1997, 272:4398-4403
41. Sargiacomo M, Sudol M, Tang Z-L, Lisanti MP: Signal transducing molecules and GPI-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J Cell Biol 1993, 122:789-807
42. Li S, Galbiati F, Volonte D, Sargiacomo M, Engelman JA, Das K, Scherer PE, Lisanti MP: Mutational analysis of caveolin-induced vesicle formation Expression of caveolin-1 recruits caveolin-2 to caveolae membranes. FEBS Lett 1998, 434:127-134
43. Simons K, Ikonen E: Functional rafts in cell membranes Nature 1997, 387:569-572
44. Lisanti MP, Scherer PE, Vidugiriene J, Tang, ZL, Hermanoski-Vosatka A, Tu Y-H, Cook RF, Sargiacomo M: Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Cell Biol 1994, 126:111-126
45. Brown DA, London E: Structure of detergent-resistant membrane domains: does phase separation occur in biological membranes? Biochem Biophys Res Commun 1997, 240:1-7
46. Brown DA, London E: Functions of lipid rafts in biological membranes. Ann Rev Cell Dev Biol 1998, 14:111-136
47. Li S, Okamoto T, Chun M, Sargiacomo M, Casanova JE, Hansen SH, Nishimoto I, Lisanti MP: Evidence for a regulated interaction between hetero-trimeric G proteins and caveolin. J Biol Chem 1995, 270: 15693-15701
48. Diep DB, Nelson KL, Raja SM, Pleshak EN, Buckley JT. Glycosylphosphatidylinositol anchors of membrane glycoproteins are binding determinants for the channel-forming toxin aerolysin. J Biol Chem 1998, 273:2355-2360
49. Hagiwara Y, Sasaoka T, Araishi K, Imamura M, Yorifuji H, Nonaka I, Ozawa E, Kikuchi T: Caveolin-3 deficiency causes muscle degeneration in mice. Hum Mol Genet 2000, 9:3047-3054
50. Sotgia F, Razani B, Bonuccelli G, Schubert W, Battista M, Lee H, Capozza F, Schubert AL, Minetti C, Buckley JT, Lisanti MP: Intracellular retention of glycosylphosphatidyl inositol-linked proteins in caveolin-deficient cells. Mol Cell Biol 2002, 22:3905-3926
51. Scherer PE, Lisanti MP, Baldini G, Sargiacomo M, Corley-Mastick C, Lodish HF: Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles J Cell Biol 1994, 127:1233-1243
52. Kandror KV, Stephens JM, Pilch PF: Expression and compartmentalization of caveolin in adipose cells: coordinate regulation with and structural segregation from GLUT4. J Cell Biol 1995, 129:999-1006
53. Karlsson M, Thorn H, Parpal S, Stralfors P, Gustavsson J: Insulin induces translocation of glucose transporter GLUT4 to plasma membrane caveolae in adipocytes. EMBO J 2002, 16:249-251
54. Friedman JE, Dudek RW, Whitehead DS, Downes DL, Frisell WR, Caro JF, Dohm GL: Immunolocalization of glucose transporter GLUT4 within human skeletal muscle Diabetes 1991, 40:150-154
55. Dohm GL, Dolan PL, Frisell WR, Dudek RW: Role of transverse tubules in insulin stimulated muscle glucose transport. J Cell Biochem 1993, 52:1-7